Literature DB >> 31844253

ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics.

He Liu1, Zhaoyue He1,2, Nina Germič1, Hyrijie Ademi1, Živa Frangež1, Andrea Felser2, Shuang Peng1, Carsten Riether3, Valentin Djonov4, Jean-Marc Nuoffer2,5, Cédric Bovet2, Irena Mlinarič-Raščan6, Inti Zlobec7, Martin Fiedler2, Aurel Perren7, Hans-Uwe Simon8,9.   

Abstract

In contrast to the "Warburg effect" or aerobic glycolysis earlier generalized as a phenomenon in cancer cells, more and more recent evidence indicates that functional mitochondria are pivotal for ensuring the energy supply of cancer cells. Here, we report that cancer cells with reduced autophagy-related protein 12 (ATG12) expression undergo an oncotic cell death, a phenotype distinct from that seen in ATG5-deficient cells described before. In addition, using untargeted metabolomics with ATG12-deficient cancer cells, we observed a global reduction in cellular bioenergetic pathways, such as β-oxidation (FAO), glycolysis, and tricarboxylic acid cycle activity, as well as a decrease in mitochondrial respiration as monitored with Seahorse experiments. Analyzing the biogenesis of mitochondria by quantifying mitochondrial DNA content together with several mitochondrion-localizing proteins indicated a reduction in mitochondrial biogenesis in ATG12-deficient cancer cells, which also showed reduced hexokinase II expression and the upregulation of uncoupling protein 2. ATG12, which we observed in normal cells to be partially localized in mitochondria, is upregulated in multiple types of solid tumors in comparison with normal tissues. Strikingly, mouse xenografts of ATG12-deficient cells grew significantly slower as compared with vector control cells. Collectively, our work has revealed a previously unreported role for ATG12 in regulating mitochondrial biogenesis and cellular energy metabolism and points up an essential role for mitochondria as a failsafe mechanism in the growth and survival of glycolysis-dependent cancer cells. Inducing oncosis by imposing an ATG12 deficiency in solid tumors might represent an anticancer therapy preferable to conventional caspase-dependent apoptosis that often leads to undesirable consequences, such as incomplete cancer cell killing and a silencing of the host immune system.

Entities:  

Year:  2019        PMID: 31844253      PMCID: PMC7244572          DOI: 10.1038/s41418-019-0476-5

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  49 in total

1.  The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis.

Authors:  Assaf D Rubinstein; Miriam Eisenstein; Yaara Ber; Shani Bialik; Adi Kimchi
Journal:  Mol Cell       Date:  2011-12-09       Impact factor: 17.970

2.  ATG12 conjugation to ATG3 regulates mitochondrial homeostasis and cell death.

Authors:  Lilliana Radoshevich; Lyndsay Murrow; Nan Chen; Estefania Fernandez; Srirupa Roy; Christopher Fung; Jayanta Debnath
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

3.  Targeting autophagy for the treatment of cancer.

Authors:  Simone Fulda
Journal:  Biol Chem       Date:  2018-06-27       Impact factor: 3.915

4.  Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis.

Authors:  Shida Yousefi; Remo Perozzo; Inès Schmid; Andrew Ziemiecki; Thomas Schaffner; Leonardo Scapozza; Thomas Brunner; Hans-Uwe Simon
Journal:  Nat Cell Biol       Date:  2006-09-24       Impact factor: 28.824

5.  Temporal analysis of recruitment of mammalian ATG proteins to the autophagosome formation site.

Authors:  Ikuko Koyama-Honda; Eisuke Itakura; Takahiro K Fujiwara; Noboru Mizushima
Journal:  Autophagy       Date:  2013-07-10       Impact factor: 16.016

6.  Ubiquitination and proteasomal degradation of ATG12 regulates its proapoptotic activity.

Authors:  Martina Haller; Andreas K Hock; Evangelos Giampazolias; Andrew Oberst; Douglas R Green; Jayanta Debnath; Kevin M Ryan; Karen H Vousden; Stephen W G Tait
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

7.  Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.

Authors:  Ji-Fan Lin; Yi-Chia Lin; Te-Fu Tsai; Hung-En Chen; Kuang-Yu Chou; Thomas I-Sheng Hwang
Journal:  Drug Des Devel Ther       Date:  2017-05-16       Impact factor: 4.162

Review 8.  Cytoplasmic vacuolization in cell death and survival.

Authors:  Andrey V Shubin; Ilya V Demidyuk; Alexey A Komissarov; Lola M Rafieva; Sergey V Kostrov
Journal:  Oncotarget       Date:  2016-08-23

9.  ATG5 is induced by DNA-damaging agents and promotes mitotic catastrophe independent of autophagy.

Authors:  Dipak Maskey; Shida Yousefi; Inès Schmid; Inti Zlobec; Aurel Perren; Robert Friis; Hans-Uwe Simon
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells.

Authors:  Jessie Yanxiang Guo; Xin Teng; Saurabh V Laddha; Sirui Ma; Stephen C Van Nostrand; Yang Yang; Sinan Khor; Chang S Chan; Joshua D Rabinowitz; Eileen White
Journal:  Genes Dev       Date:  2016-08-11       Impact factor: 11.361

View more
  10 in total

1.  Liensinine Inhibits Cell Growth and Blocks Autophagic Flux in Nonsmall-Cell Lung Cancer.

Authors:  Minghui Chang; Shanshan Ding; Xiaohan Dong; Xiaoling Shang; Yang Li; Li Xie; Xingguo Song; Xianrang Song
Journal:  J Oncol       Date:  2022-07-01       Impact factor: 4.501

2.  Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis.

Authors:  Xingzhen Cheng; Fang Yang; Yang Wang; Wei Nie; Adarsha Mahendra Upadhyay; Maolin Zhang; Qian Wang; Zhiqiang Yan
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-10

3.  SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury.

Authors:  Ting Xin; Chengzhi Lu
Journal:  Aging (Albany NY)       Date:  2020-07-28       Impact factor: 5.682

Review 4.  The role of neutrophil death in chronic inflammation and cancer.

Authors:  Christine Brostjan; Rudolf Oehler
Journal:  Cell Death Discov       Date:  2020-04-22

Review 5.  Serine and one-carbon metabolisms bring new therapeutic venues in prostate cancer.

Authors:  Carlo Ganini; Ivano Amelio; Riccardo Bertolo; Eleonora Candi; Angela Cappello; Chiara Cipriani; Alessandro Mauriello; Carla Marani; Gerry Melino; Manuela Montanaro; Maria Emanuela Natale; Giuseppe Tisone; Yufang Shi; Ying Wang; Pierluigi Bove
Journal:  Discov Oncol       Date:  2021-10-27

6.  Disruption of mitochondrial quality control genes promotes caspase-resistant cell survival following apoptotic stimuli.

Authors:  Yulia Kushnareva; Vivian Moraes; Julian Suess; Bjoern Peters; Donald D Newmeyer; Tomomi Kuwana
Journal:  J Biol Chem       Date:  2022-03-16       Impact factor: 5.486

7.  Nascent RHOH acts as a molecular brake on actomyosin-mediated effector functions of inflammatory neutrophils.

Authors:  Shuang Peng; Darko Stojkov; Jian Gao; Kevin Oberson; Philipp Latzin; Carmen Casaulta; Shida Yousefi; Hans-Uwe Simon
Journal:  PLoS Biol       Date:  2022-09-15       Impact factor: 9.593

8.  Metformin and Vitamin D Modulate Inflammation and Autophagy during Adipose-Derived Stem Cell Differentiation.

Authors:  Sara Cruciani; Giuseppe Garroni; Renzo Pala; Maria Laura Cossu; Giorgio Carlo Ginesu; Carlo Ventura; Margherita Maioli
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

Review 9.  Autophagy Takes Center Stage as a Possible Cancer Hallmark.

Authors:  Jose G Alvarez-Meythaler; Yoelsis Garcia-Mayea; Cristina Mir; Hiroshi Kondoh; Matilde E LLeonart
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

10.  A Continuous Add-On Probe Reveals the Nonlinear Enlargement of Mitochondria in Light-Activated Oncosis.

Authors:  Kang-Nan Wang; Xintian Shao; Zhiqi Tian; Liu-Yi Liu; Chengying Zhang; Cai-Ping Tan; Jie Zhang; Peixue Ling; Fei Liu; Qixin Chen; Jiajie Diao; Zong-Wan Mao
Journal:  Adv Sci (Weinh)       Date:  2021-07-01       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.